AI
| Followers | 843 |
| Posts | 122806 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Wednesday, April 24, 2013 10:04:02 PM
Interim data from BMY’s 3-drug cocktail to be presented at EASL:
The three drugs in the cocktail are Daclatasvir (NS5A), Asunaprevir (PI), and BMS-791325 (non-nuke). Two doses of BMS-791325 were tested, but much of the data for the higher dose (150mg BID) are not yet mature.
Note that there was one viral breakthrough and one relapse in the 12-week cohort for the higher dose of BMS-791325.
The three drugs in the cocktail are Daclatasvir (NS5A), Asunaprevir (PI), and BMS-791325 (non-nuke). Two doses of BMS-791325 were tested, but much of the data for the higher dose (150mg BID) are not yet mature.
Note that there was one viral breakthrough and one relapse in the 12-week cohort for the higher dose of BMS-791325.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
